BioInvent Soars After Positive Study Results: Stockholm Mover

BioInvent International AB, a Swedish biotechnology company, led gainers in the OMX Stockholm All-Share Index after announcing positive results in a study of patients with multiple myeloma.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.